Previous Article | Next Article 
Infection and Immunity, February 2001, p. 810-815, Vol. 69, No. 2
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.2.810-815.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Trehalose 6,6'-Dimycolate (Cord Factor) of
Mycobacterium tuberculosis Induces Foreign-Body- and
Hypersensitivity-Type Granulomas in Mice
Hirokazu
Yamagami,1,2,*
Takayuki
Matsumoto,2
Nagatoshi
Fujiwara,1
Tetsuo
Arakawa,2
Kenji
Kaneda,3
Ikuya
Yano,4 and
Kazuo
Kobayashi1
Departments of Host
Defense,1
Gastroenterology,2 and
Anatomy,3 Osaka City University Graduate
School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, and
Institute of BCG, Kiyose-shi, Tokyo
204-0022,4 Japan
Received 17 July 2000/Returned for modification 14 September
2000/Accepted 8 November 2000
 |
ABSTRACT |
Granulomatous inflammation is characterized morphologically by a
compact organized collection of macrophages and their derivatives. It
is classified as either a hypersensitivity type or a foreign-body type.
Lipid components of the Mycobacterium tuberculosis cell wall participate in the pathogenesis of infection. Strains of M. tuberculosis have cord factor (trehalose 6,6'-dimycolate [TDM]) on their surface. To clarify host responses to TDM, including immunogenicity and pathogenicity, we have analyzed the footpad reaction, histopathology, and cytokine profiles of experimental granulomatous lesions in immunized and unimmunized mice challenged with
TDM. In the present study, we have demonstrated for the first time that
TDM can induce both foreign-body-type (nonimmune) and hypersensitivity-type (immune) granulomas by acting as a nonspecific irritant and T-cell-dependent antigen. Immunized mice challenged with
TDM developed more severe lesions than unimmunized mice. At the active
lesion, we found monocyte chemotactic, proinflammatory, and
immunoregulatory cytokines. The level was enhanced in immunized mice
challenged with TDM. This result implies that both nonimmune and immune
mechanisms participate in granulomatous inflammation induced by
mycobacterial infection. Taken together with a previous report, this
study shows that TDM is a pleiotropic molecule against the host and
plays an important role in the pathogenesis of tuberculosis.
 |
INTRODUCTION |
The pathogenesis of tuberculosis is
a function of the pathogen, Mycobacterium tuberculosis, and
of the immune response of the host to the pathogen (5,
14). Tuberculosis is a chronic infection with M. tuberculosis complex, including M. tuberculosis and
Mycobacterium bovis, that is characterized morphologically by granulomatous inflammation, a compact organized collection of
macrophages and their derivatives, such as epithelioid and giant cells,
at the site of infection (19). The pathogenicity of
M. tuberculosis is related to its ability to escape killing by macrophages and induce delayed-type hypersensitivity (DTH) (5,
14, 19).
Granulomatous inflammation can be broadly classified as either a
hypersensitivity (immunologic, T-cell-dependent) type or a foreign-body
(nonimmunologic, T-cell-independent) type (19, 20). There
is much known, but we still have a long way to go to understand the
mechanism of M. tuberculosis pathogenicity. Mycobacteria are
rich in lipids. Lipid components of the M. tuberculosis cell
wall participate in pathogenesis. Cord factor (trehalose 6,6'-dimycolate [TDM]), a surface glycolipid, causes M. tuberculosis to grow in serpentine cords in vitro. Virulent
strains of M. tuberculosis have TDM on their surface
(2), and injection of purified TDM into experimental
animals induces lesions characterized by chronic granulomatous
inflammation (6, 29).
To clarify host responses to mycobacterial TDM, including
immunogenicity and pathogenicity, we have analyzed the footpad
reactions, histopathology, and cytokine profiles of experimental
granulomatous lesions in immunized and unimmunized mice challenged with TDM.
 |
MATERIALS AND METHODS |
Animals.
Specific-pathogen-free female euthymic and athymic
nude nu/nu BALB/c mice at 8 weeks of age were purchased from SLC
(Shizuoka, Japan). Experiments were conducted according to the standard
guidelines for animal experiments of Osaka City University Graduate
School of Medicine.
Preparation of TDM.
M. tuberculosis Aoyama B was
grown in Sauton medium for 5 weeks at 37°C. Glycolipids were serially
extracted with chloroform-methanol at 4:1, (vol/vol), 3:1, and 2:1.
Each mycolate was purified by developing the lipids on a thin-layer
plate of silica gel (Analtech, Inc., Newark, Del.) with
chloroform-methanol-acetone-acetic acid (90:10:6:1) and subsequently
with chloroform-methanol-water (90:10:1). This procedure was repeated
until a single spot was obtained (25). The preparation
contained less than 80 ng of protein/100 µg of TDM, as determined by
a protein assay kit (Bio-Rad, Hercules, Calif.).
Preparation of w/o/w emulsion.
To prepare 100 µl of
sample, 100 µg of purified TDM was dissolved in 3.2 µl of Freund's
incomplete adjuvant (FIA) (Difco Laboratories, Detroit, Mich.) in a
Teflon grinder. After addition of 3.2 µl of 0.1 M phosphate-buffered
saline (PBS), a water-in-oil emulsion was made. Then, 93.6 µl of
saline containing 0.2% Tween 80 was added at the final concentration
(3.2%) of FIA, and a water-in-oil-in-water (w/o/w) emulsion was made
by mixing (28). As controls, w/o/w micelles without TDM
were used.
Immunization.
Mice were immunized by subcutaneous injections
of 100 µg of methylated bovine serum albumin (MBSA) (Sigma Chemical
Co., St. Louis, Mo.) emulsified with Freund's complete adjuvant (FCA)
into the inguinal region, the front footpad, and the base of the tail. FCA was prepared by adding heat-killed M. tuberculosis
Aoyama B in FIA at a concentration of 2 mg/ml (15).
Footpad assays for DTH.
Eight days after immunization, hind
footpads were challenged with 20 µl of TDM (1 mg/ml) in the form of
w/o/w emulsion, w/o/w micelles alone, MBSA (1 mg/ml), or egg albumin (1 mg/ml) (grade V; Sigma Chemical Co.). Five mice were used for each
group. Triplicate measurements of footpad thickness were performed with
an engineer's micrometer (Mitsutoyo Co., Kanagawa, Japan) before and
24 h after the challenge (15). The difference between
the measurements was calculated and expressed as the mean ± standard deviation (SD) in millimeters.
Induction of pulmonary granulomas.
Ten days after
immunization, mice were injected intravenously with either 100 µg of
TDM in 100 µl of w/o/w emulsion, 100 µl of w/o/w micelles alone, or
100 µg of MBSA in 100 µl of PBS. Unimmunized mice were similarly
challenged. To exclude the possibility of boosting with repeated TDM
exposures, we used two different sets of mice for DTH footpad assays
and induction of lung granulomas throughout the study.
Determination of lung index.
To determine the activity of
granulomatous inflammation, lung indices were used. Previous reports
have indicated that a considerable proportion of the increase in lung
weight as a consequence of granulomatous inflammation is due to an
increase in cellularity in the organ (15, 30). The index
was calculated as follows (6): lung index = lung
weight (grams) × 100/body weight (grams).
Histology.
Lungs were fixed with 10% formalin for 5 days,
dehydrated, and embedded in paraffin (15). Sections were
stained with hematoxylin and eosin. For immunohistochemical analysis
(13), lungs were fixed in a periodate-lysine-3%
paraformaldehyde solution overnight at 4°C and then frozen in liquid
nitrogen. Sections were made using a CM3000 cryostat (Leica Instruments
GmbH, Nussloch, Germany) and immediately air dried. To block endogenous
peroxidase activity, the sections were incubated with 0.3% hydrogen
peroxide in methanol for 20 min at room temperature. After washing with
PBS, the sections were incubated with normal rat serum for 20 min at
room temperature. Subsequently, sections were incubated with diluted
rat anti-mouse CD4 monoclonal antibody (1:300) (RM4-5; Pharmingen, San
Diego, Calif.) overnight at 4°C. After being washed with PBS, they
were treated with diluted biotinylated anti-rat immunoglobulin G
antibody (1:400) (Dako, Copenhagen, Denmark) for 60 min at room
temperature, followed by incubation with avidin-biotin-peroxidase
complex (Vectastain kit; Vector Laboratories, Burlingame, Calif.).
Reaction products were visualized after incubation with 0.025%
diaminobenzidine and 0.003% hydrogen peroxide.
Enumeration of infiltrating cells.
The number of
CD4+ cells in immunostained sections of the lung was
counted 3 days after the challenge with TDM or w/o/w micelles in
unimmunized and immunized mice. Three mice were used for each group,
and 10 microscopic fields at a magnification of ×200 were randomly
selected. The average number per microscopic field (0.34 mm2) was then calculated.
Protein expression of chemokines and cytokines in the lung.
Aqueous extracts of granulomatous lungs were prepared by a method
described previously (15, 30). Briefly, lungs were
inflated with 1 ml of PBS and homogenized in 1 ml of saline by using a Polytron (Brinkmann Instruments, Westbury, N.Y.) for 30 s.
Homogenized tissues were then centrifuged in a refrigerated unit at
5,000 × g for 30 min, and the tissue pellet was
discarded. Protein concentrations were determined with a protein assay
kit (Bio-Rad). Aqueous lung extracts contained 2 to 4 mg of protein per
ml of PBS (15, 30). The contents of cytokines and
chemokines were measured by commercially available enzyme immunoassay
(EIA) kits for murine interleukin-1
(IL-1
), IL-4, IL-12, tumor
necrosis factor alpha (TNF-
), gamma interferon (IFN-
), macrophage
inflammatory protein-1
(MIP-1
), and monocyte chemotactic
protein-1 (MCP-1) (Genzyme, Minneapolis, Minn.) and expressed as the
amount per milligram of protein in the extract. The sensitivity was
<3.0 pg/ml for IL-1
, <2.0 pg/ml for IL-4, <2.5 pg/ml for IL-12,
<5.1 pg/ml for TNF-
, <2.0 pg/ml for IFN-
, <1.5 pg/ml for
MIP-1
, and <2.0 pg/ml for MCP-1, according to the manufacturer's
instructions. The EIA was conducted in duplicate.
Statistical analyses.
Data were analyzed with a Power
Macintosh G3 using StatView 5.0 (SAS Institute Inc., Cary, N.C.) and
expressed as the mean ± SD. Data that appeared to be
statistically significant were compared by an analysis of variance for
comparing the means of multiple groups and were considered significant
if P values were less than 0.05.
 |
RESULTS |
Induction of footpad DTH responses by TDM.
We found
delayed-type footpad responses to specific antigens (TDM and MBSA) in
immunized euthymic mice (Table 1).
Although footpad responses induced by TDM, but not by MBSA, were seen
in unimmunized euthymic mice and in athymic nude mice regardless of
immunization, these responses were significantly lower than those in
immunized euthymic mice. Regardless of immunization, w/o/w vehicles
alone induced mild swelling of footpads. An irrelevant antigen, egg
albumin, could not elicit the response. TDM could elicit both
antigen-specific and nonspecific responses in euthymic mice, although
athymic mice showed only nonspecific inflammatory responses.
Granulomatous inflammation of the lung.
It has been
demonstrated that intravenously injected TDM micelles are trapped in
alveolar vessels and induce granulomatous inflammation of the lung
(6, 8). A significant increase of lung indices was found
in immunized euthymic mice 3 to 7 days after the challenge with TDM
compared with unimmunized mice (Fig. 1).
Regardless of immunization, athymic nude mice showed a moderate increase in the index. The kinetics and intensity were similar to those
of unimmunized mice. The level showed a marked increase within 3 days,
reached the maximum by day 7, and gradually declined thereafter. No
significant increase was found in euthymic and athymic mice
challenged with w/o/w alone or MBSA regardless of immunization.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 1.
Lung indices of unimmunized and immunized mice. The
results are expressed as the mean ± SD obtained from three to six
mice for each condition. The asterisks indicate a P value of
<0.01, compared to unimmunized mice.
|
|
Histopathologic features of the lung.
In unimmunized euthymic
mice challenged with TDM, there was mild, diffuse and inflammatory cell
infiltration in alveolar and perivascular areas at early stages (1 to 3 days) (Fig. 2).
The infiltrate was composed primarily
of macrophages, lymphocytes, and scattered neutrophils. At 1 and 2 weeks after the challenge, such mice showed randomly distributed,
organized granulomas composed of macrophages and lymphocytes. The
lesions subsided thereafter. Unimmunized mice challenged with w/o/w
micelles exhibited no significant lesions. By contrast, accelerated and
augmented lesions, including cell infiltration and granuloma formation
in the alveolar and perivascular regions, were found in immunized
euthymic mice challenged with TDM but not in those challenged with
w/o/w micelles. The lesions in immunized mice were composed of
macrophages, lymphocytes, and a few neutrophils. Athymic nude mice
challenged with TDM, regardless of prior immunization, developed
lesions that were similar to those in unimmunized mice.

View larger version (138K):
[in this window]
[in a new window]
|
FIG. 2.
Histopathologic features of the lung. In
unimmunized euthymic mice challenged with TDM, mild, diffuse and
inflammatory cell infiltration in alveolar and perivascular areas at
early stages (1 to 3 days). The infiltrate was composed primarily of
macrophages, lymphocytes, and scattered neutrophils. One week after the
challenge, such mice showed organized granulomas (arrowheads) composed
of macrophages and lymphocytes. The lesions subsided thereafter.
Unimmunized mice challenged with w/o/w micelles exhibited no
significant lesions. By contrast, accelerated and augmented
granulomatous lesions were found in immunized euthymic mice challenged
with TDM but not in those challenged with w/o/w micelles. The lesions
in immunized mice were composed of macrophages, lymphocytes, and a few
neutrophils. In athymic nude mice, slight granuloma formation was seen
at day 7 regardless of preimmunization. Hematoxylin and eosin staining
was used. Bar, 200 µm.
|
|
Immunohistochemical studies demonstrated that CD4+ cells
(Th cells) were abundant in granulomas and perivascular cell
infiltration of unimmunized and immunized mice 3 days after TDM
challenge, although the number of CD4+ cells was
significantly increased in immunized mice compared to unimmunized mice
(Fig. 3). Regardless of preimmunization,
the number did not differ in mice challenged with w/o/w alone.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 3.
Immunocytochemical analyses of CD4-positive cells in the
lesion. The number of CD4+ cells per unit square (0.34 mm2) in the lungs of unimmunized and immunized mice was
calculated 3 days after the challenge with either TDM or w/o/w micelles
alone. Ten microscopic fields were examined at a magnification of
×200. Data represent the mean ± SD from three mice. The asterisk
indicates a P value of <0.05 compared to unimmunized
mice.
|
|
Protein expression of chemokines and cytokines.
We next
studied the profile of cytokines and chemokines in the lung (Fig.
4), because a prominent accumulation of
mononuclear cells, such as granulomatous inflammation, was seen. A
significant amount of CC chemokines, including MCP-1 and MIP-1
, was
detected in lung extracts from immunized mice challenged with TDM
compared to unimmunized mice. In immunized and unimmunized mice, the
peak activity was present 1 to 3 days after the challenge and declined thereafter. Lung extracts from mice challenged with w/o/w micelles alone contained a smaller amount of CC chemokines regardless of preimmunization. Proinflammatory cytokines such as IL-1
and TNF-
were prominent in immunized mice challenged with TDM. In contrast to
the case for immunized mice, the level of proinflammatory cytokines in
the extracts from unimmunized mice challenged with w/o/w micelles alone
was not only considerably less but also was maintained for a shorter
time. A considerable amount of Th1- and IFN-
-inducing immunoregulatory cytokines, IL-12 and IFN-
, was detected in the extracts prepared from immunized mice challenged with TDM, but there
was much less from immunized mice challenged with w/o/w micelles alone
and unimmunized mice challenged with TDM. The peak was reached by day
3, and the level declined thereafter. Regardless of prior immunization,
IL-4 was not found in the extracts from mice challenged with TDM or
w/o/w micelles alone (data not shown). To examine the effects of the
procedure on enzymatic degradation and half-lives of cytokines, we
measured cytokine levels in the extracts prepared from either immunized
or unimmunized mice in the presence of standard recombinant cytokines,
including chemokines. The results showed that the levels of all
cytokines tested in our study were not affected by procedures of
immunization and extract preparation (data not shown).

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 4.
Protein expression of chemokines and cytokines in the
lung. Results represent the mean ± SD from three (unimmunized) or
six (immunized) mice challenged with TDM, w/o/w micelles, or MBSA. The
asterisks indicate a P value of <0.05 compared to
unimmunized mice. The EIA was conducted in duplicate.
|
|
 |
DISCUSSION |
In the present study, we have demonstrated for the first time that
TDM derived from virulent M. tuberculosis can induce both foreign-body-type (nonimmune) and hypersensitivity-type (immune) granulomas by acting as a nonspecific irritant and a T-cell-dependent antigen. This result implies that both nonimmune and immune mechanisms participate in granulomatous inflammation induced by mycobacterial infection.
Granulomatous inflammation is manifested in chronic inflammatory
diseases that often result in tissue destruction and end-stage fibrosis. The common histologic feature of granulomatous inflammation, i.e., infiltrating mononuclear leukocytes and their derivatives (epithelioid cells and multinucleated giant cells), is observed in a
variety of granulomatous diseases caused by infectious agents (tuberculosis, leprosy, schistosomiasis, leishmaniasis, and
histoplasmosis), non-infectious agents (silicosis and berylliosis), or
unknown agents (sarcoidosis, Crohn's disease, and Wegener's
granulomatosis) (20). The lesion is usually surrounded by
a collar of lymphocytes and occasionally eosinophils. Granulomatous
inflammation can be broadly classified as either a hypersensitivity
(immunologic, T-cell-dependent) type or a foreign-body (nonimmunologic,
T-cell-independent) type (19, 20). The classification is
based on the participation of antigen-specific T lymphocytes in the
lesions. The granulomas induced by M. bovis bacillus
Calmette-Guérin (BCG) in mice were developed regardless of
preimmunization with M. tuberculosis or BCG, although
augmented lesions were observed in preimmunized mice (15,
30).
Disease progression to active tuberculosis is dependent on an interplay
between bacterial and host factors. Mycobacteria are rich in lipids.
These include mycolic acids, which are long-chain fatty acids
(C78 to C90) (2). The
pathogenicity of M. tuberculosis is related to its ability
to induce cell-mediated immunity and DTH. (5). Strains of
M. tuberculosis have cord factor (TDM), a surface
glycolipid. A variety of foreign lipids and glycolipids, including
several found in the cell walls and cell membranes of pathogenic
mycobacteria, are recognized by CD1-restricted T cells in humans, and
the CD1 system provides a novel mechanism for host responses to
mycobacterial infection, such as the development of cell-mediated
immunity (21, 27). To confirm the contribution of T cells
in TDM-induced hypersensitivity, it is necessary to demonstrate
TDM-specific T cells, although in the present study this was not done.
This approach will also explore the possibility that the putative
T-cell contribution might arise from contamination with minute amounts
of protein in the TDM preparation. The immune response to microbial
pathogens relies on both innate and adaptive components. The role of
CD1, CD14, and Toll-like receptors (1, 26) in host
responses to TDM is intriguing, although this is not addressed in our
present study. Future studies are needed to clarify the issue.
In the present study we have demonstrated that TDM can induce
hypersensitivity granulomas in euthymic mice immunized with FCA and
also can elicit foreign-body lesions in unimmunized euthymic and
athymic nude mice. This contention is supported by the result that
footpad DTH responses to TDM were augmented in immunized mice compared
to unimmunized euthymic and athymic nude mice. In addition, TDM itself
acts as a nonspecific inflammatory stimulus, because similar and
moderate footpad swelling was observed in euthymic and athymic mice.
The precise mechanism of the delayed granulomatous response in athymic
nude mice remains unknown, however, mature T lymphocytes may be
involved in the response, because athymic mice lack them. Collectively,
our results imply that mechanisms of granulomatous inflammation in
tuberculosis are composed of both foreign-body and hypersensitivity types.
Granuloma formation is the expression of a series of complex
inflammatory events. Evidence suggests that proinflammatory cytokines play important roles in the initiation and maintenance of granuloma formation (9, 10, 31). Histopathologically, the bulk of both hypersensitive and foreign-body granulomas are composed of macrophages and their derivatives. In most tissues the presence of
inflammatory macrophages results from the recruitment of peripheral blood monocytes. Besides granulomas, our studies showed prominent perivascular infiltration of mononuclear cells around the lesion. This
may be attributed to recruitment of blood and tissue mononuclear cells
through local expression of CC chemokines for monocytes and
lymphocytes, such as MCP-1 and MIP-1
(4, 7). MIP-1
is known to be an efficient chemoattractant for Th1 cells, although MCP-1 exerts chemotactic activity for both Th1 and Th2 cells
(32). This may lead to expression of cell-mediated
immunity in immunized mice challenged with TDM, because the expression
of MIP-1
(days 1 to 3) persisted longer than that of MCP-1 (day 1)
in the lesion.
The very early expression of CC chemokines was detected within 1 to 3 days after the challenge with TDM. Human blood monocytes preferentially
produce CC chemokines in response to M. tuberculosis (11, 12). Both MCP-1 and MIP-1
may be pivotal in the
initial recruitment of monocytes to sites of subsequent granuloma
formation. It has been demonstrated that proinflammatory cytokines such
as IL-1 and TNF-
participate in granulomatous inflammation (9, 10, 19, 20, 31), although they lack direct chemotactic activity
for monocytes (22). However, chemokines are inducible by
stimulating macrophages/monocytes with IL-1 and TNF-
(23). The cytokine network may form a powerful
amplification circuit of granulomatous inflammation.
IL-12, a cytokine produced mainly by macrophages in response to
mycobacteria, augments cytotoxicity and cytokine production by T cells
and NK cells and initiates development of CD4+ Th1 cells
(33). CD4+ Th1 and NK cells stimulated with
IL-12 produce and secrete IFN-
, which activates macrophages to
inhibit or kill intracellular mycobacteria via reactive nitrogen
intermediates (3). Thus, macrophages accumulate at the
site of microbial growth and become activated through the
CD4+ Th1 cell-cytokine-macrophage axis (14).
IL-12 induces the differentiation of Th1 cells from uncommitted T cells
and, consequently, initiates cell-mediated immunity, which plays a
protective role in infections with mycobacteria. This cytokine
represents an important regulatory bridge between innate resistance and
adaptive immunity.
TDM can stimulate production of IL-12 from mouse macrophages
(24), and IL-12 is found in the active lesion elicited by
experimental mycobacterial infection in mice, including that with
Mycobacterium avium (17, 18) and
Mycobacterium leprae (16). In immunized mice
challenged with TDM, lesional IL-12 and IFN-
reached peak levels
concomitantly 3 days after challenge, whereas unimmunized mice express
less of them. The temporal profiles of IL-12 and IFN-
may indicate
their close functional relationship. Our data that mice bearing
granulomas showed significant expression of IL-12 and IFN-
but not
IL-4 suggest that TDM challenge may favor dominance of the Th1 response
via through the local cytokine profile. Indeed, such mice did not
produce anti-TDM antibodies that might reflect a Th2 response (data not shown).
Infection with mycobacteria results in either host defense or disease
expression such as granulomatous inflammation (5, 14, 19).
Our present study suggests that TDM, a surface glycolipid derived from
the cell walls of virulent strains of M. tuberculosis, plays
a critical role in the process. Taken together with the previous
reports that mycobacterial TDM can induce apoptosis (6) and angiogenesis (29), this study indicates that TDM is a
pleiotropic molecule against the host and participates in the
pathogenesis of tuberculosis.
 |
ACKNOWLEDGMENTS |
This work was supported by grants from the Ministry of
Health and Welfare (Research on Emerging and Re-emerging Infectious Diseases, Health Sciences Research Grants) and the U.S.-Japan Cooperative Medical Science Program against Tuberculosis and Leprosy.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Host Defense, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan. Phone: 81-6-6645-3746. Fax: 81-6-6645-3747. E-mail:
yamagami{at}med.osaka-cu.ac.jp.
Editor:
T. R. Kozel
 |
REFERENCES |
| 1.
|
Aderem, A., and R. J. Ulevitch.
2000.
Toll-like receptors in the induction of the innate immune response.
Nature
406:782-787[CrossRef][Medline].
|
| 2.
|
Besra, G. S., and D. Chatterjee.
1994.
Lipids and carbohydrates of Mycobacterium tuberculosis, p. 285-306.
In
B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. ASM Press, Washington, D.C.
|
| 3.
|
Chan, J.,
Y. Xing,
R. S. Magliozzo, and B. R. Bloom.
1992.
Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages.
J. Exp. Med.
175:1111-1122[Abstract/Free Full Text].
|
| 4.
|
Chensue, S. W.,
K. S. Warmington,
J. H. Ruth,
P. S. Sanghi,
P. Lincoln, and K. S. L..
1996.
Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: relationship to local inflammation, Th cell expression, and IL-12 production.
J. Immunol.
157:4602-4607[Abstract].
|
| 5.
|
Dannenberg, A. M., Jr.
1991.
Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis.
Immunol. Today
12:228-233[CrossRef][Medline].
|
| 6.
|
Hamasaki, N.,
K. I. Isowa,
K. Kamada,
Y. Terano,
T. Matsumoto,
T. Arakawa,
K. Kobayashi, and I. Yano.
2000.
In vivo administration of mycobacterial cord factor (trehalose 6,6'-dimycolate) can induce lung and liver granulomas and thymic atrophy in rabbits.
Infect. Immun.
68:3704-3709[Abstract/Free Full Text].
|
| 7.
|
Hogaboam, C. M.,
C. L. Bone-Larson,
S. Lipinski,
N. W. Lukacs,
S. W. Chensue,
R. M. Strieter, and S. L. Kunkel.
1999.
Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1- and Th2-type pulmonary granuloma models.
J. Immunol.
163:2193-2201[Abstract/Free Full Text].
|
| 8.
|
Kaneda, K.,
Y. Sumi,
F. Kurano,
Y. Kato, and I. Yano.
1986.
Granuloma formation and hemopoiesis induced by C36-48-mycolic acid-containing glycolipids from Nocardia rubra.
Infect. Immun.
54:869-875[Abstract/Free Full Text].
|
| 9.
|
Kasahara, K.,
K. Kobayashi,
Y. Shikama,
I. Yoneya,
S. Kaga,
M. Hashimoto,
T. Odagiri,
K. Soejima,
H. Ide,
T. Takahashi, et al.
1989.
The role of monokines in granuloma formation in mice: the ability of interleukin 1 and tumor necrosis factor- to induce lung granulomas.
Clin. Immunol. Immunopathol.
51:419-425[CrossRef][Medline].
|
| 10.
|
Kasahara, K.,
K. Kobayashi,
Y. Shikama,
I. Yoneya,
K. Soezima,
H. Ide, and T. Takahashi.
1988.
Direct evidence for granuloma-inducing activity of interleukin-1. Induction of experimental pulmonary granuloma formation in mice by interleukin-1-coupled beads.
Am. J. Pathol.
130:629-638[Abstract].
|
| 11.
|
Kasahara, K.,
I. Sato,
K. Ogura,
H. Takeuchi,
K. Kobayashi, and M. Adachi.
1998.
Expression of chemokines and induction of rapid cell death in human blood neutrophils by Mycobacterium tuberculosis.
J. Infect. Dis.
178:127-137[Medline].
|
| 12.
|
Kasahara, K.,
T. Tobe,
M. Tomita,
N. Mukaida,
S. Shao-Bu,
K. Matsushima,
T. Yoshida,
S. Sugihara, and K. Kobayashi.
1994.
Selective expression of monocyte chemotactic and activating factor/monocyte chemoattractant protein 1 in human blood monocytes by Mycobacterium tuberculosis.
J. Infect. Dis.
170:1238-1247[Medline].
|
| 13.
|
Kasama, T.,
J. Yamazaki,
R. Hanaoka,
Y. Miwa,
Y. Hatano,
K. Kobayashi,
M. Negishi,
H. Ide, and M. Adachi.
1999.
Biphasic regulation of the development of murine type II collagen-induced arthritis by interleukin-12: possible involvement of endogenous interleukin-10 and tumor necrosis factor .
Arthritis Rheum.
42:100-109[CrossRef][Medline].
|
| 14.
|
Kaufmann, S. H. E.
1995.
Immunity to intracellular microbial pathogens.
Immunol. Today
16:338-343[CrossRef][Medline].
|
| 15.
|
Kobayashi, K.,
C. Allred,
R. Castriotta, and T. Yoshida.
1985.
Strain variation of bacillus Calmette-Guerin-induced pulmonary granuloma formation is correlated with anergy and the local production of migration inhibition factor and interleukin 1.
Am. J. Pathol.
119:223-235[Abstract].
|
| 16.
|
Kobayashi, K.,
M. Kai,
M. Gidoh,
N. Nakata,
M. Endoh,
R. P. Singh,
T. Kasama, and H. Saito.
1998.
The possible role of interleukin (IL)-12 and interferon- -inducing factor/IL-18 in protection against experimental Mycobacterium leprae infection in mice.
Clin. Immunol. Immunopathol.
88:226-231[CrossRef][Medline].
|
| 17.
|
Kobayashi, K.,
N. Nakata,
M. Kai,
T. Kasama,
Y. Hanyuda, and Y. Hatano.
1997.
Decreased expression of cytokines that induce type 1 helper T cell/interferon- responses in genetically susceptible mice infected with Mycobacterium avium.
Clin. Immunol. Immunopathol.
85:112-116[CrossRef][Medline].
|
| 18.
|
Kobayashi, K.,
J. Yamazaki,
T. Kasama,
T. Katsura,
K. Kasahara,
S. F. Wolf, and T. Shimamura.
1996.
Interleukin (IL)-12 deficiency in susceptible mice infected with Mycobacterium avium and amelioration of established infection by IL-12 replacement therapy.
J. Infect. Dis.
174:564-573[Medline].
|
| 19.
|
Kobayashi, K., and T. Yoshida.
1996.
The immunopathogenesis of granulomatous inflammation induced by Mycobacterium tuberculosis.
Methods
9:204-214[CrossRef][Medline].
|
| 20.
|
Kunkel, S. L.,
S. W. Chensue,
R. M. Strieter,
J. P. Lynch, and D. G. Remick.
1989.
Cellular and molecular aspects of granulomatous inflammation.
Am. J. Respir. Cell Mol. Biol.
1:439-448.
|
| 21.
|
Moody, D. B.,
B. B. Reinhold,
M. R. Guy,
E. M. Beckman,
D. E. Frederique,
S. T. Furlong,
S. Ye,
V. N. Reinhold,
P. A. Sieling,
R. L. Modlin,
G. S. Besra, and S. A. Porcelli.
1997.
Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells.
Science
278:283-286[Abstract/Free Full Text].
|
| 22.
|
Oppenheim, J. J., and R. Neta.
1994.
Pathophysiological roles of cytokines in development, immunity, and inflammation.
FASEB J.
8:158-162[Medline].
|
| 23.
|
Oppenheim, J. J.,
C. O. C. Zachariae,
N. Mukaida, and K. Matsushima.
1991.
Properties of the novel proinflammatory supergene "intercrine" cytokine family.
Annu. Rev. Immunol.
9:617-648[Medline].
|
| 24.
|
Oswald, I. P.,
C. M. Dozois,
J. F. Petit, and G. Lemaire.
1997.
Interleukin-12 synthesis is a required step in trehalose dimycolate-induced activation of mouse peritoneal macrophages.
Infect. Immun.
65:1364-1369[Abstract].
|
| 25.
|
Ozeki, Y.,
K. Kaneda,
N. Fujiwara,
M. Morimoto,
S. Oka, and I. Yano.
1997.
In vivo induction of apoptosis in the thymus by administration of mycobacterial cord factor (trehalose 6,6'-dimycolate).
Infect. Immun.
65:1793-1799[Abstract].
|
| 26.
|
Park, S. H., and A. Bendelac.
2000.
CD1-restricted T-cell responses and microbial infection.
Nature
406:788-792[CrossRef][Medline].
|
| 27.
|
Porcelli, S. A., and R. L. Modlin.
1999.
The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids.
Annu. Rev. Immunol.
17:297-329[CrossRef][Medline].
|
| 28.
|
Saita, N.,
N. Fujiwara,
I. Yano,
K. Soejima, and K. Kobayashi.
2000.
Trehalose 6,6'-dimycolate (cord factor) of Mycobacterium tuberculosis induces corneal angiogenesis in rats.
Infect. Immun.
68:5991-5997[Abstract/Free Full Text].
|
| 29.
|
Sakaguchi, I.,
N. Ikeda,
M. Nakayama,
Y. Kato,
I. Yano, and K. Kaneda.
2000.
Trehalose 6,6'-dimycolate (cord factor) enhances neovascularization through vascular endothelial growth factor production by neutrophils and macrophages.
Infect. Immun.
68:2043-2052[Abstract/Free Full Text].
|
| 30.
|
Sato, I. Y.,
K. Kobayashi,
T. Kasama,
S. Kaga,
K. Kasahara,
H. Kanemitsu,
K. Nakatani,
T. Takahashi,
R. M. Nakamura,
E. Skamene, and T. Yoshida.
1990.
Regulation of Mycobacterium bovis BCG and foreign body granulomas in mice by the Bcg gene.
Infect. Immun.
58:1210-1216[Abstract/Free Full Text].
|
| 31.
|
Shikama, Y.,
K. Kobayashi,
K. Kasahara,
S. Kaga,
M. Hashimoto,
I. Yoneya,
S. Hosoda,
K. Soejima,
H. Ide, and T. Takahashi.
1989.
Granuloma formation by artificial microparticles in vitro. Macrophages and monokines play a critical role in granuloma formation.
Am. J. Pathol.
134:1189-1199[Abstract].
|
| 32.
|
Siveke, J. T., and A. Hamann.
1998.
T helper 1 and T helper 2 cells respond differentially to chemokines.
J. Immunol.
160:550-554[Abstract/Free Full Text].
|
| 33.
|
Trinchieri, G.
1995.
Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity.
Annu. Rev. Immunol.
13:251-276[Medline].
|
Infection and Immunity, February 2001, p. 810-815, Vol. 69, No. 2
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.2.810-815.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Welsh, K. J., Abbott, A. N., Hwang, S.-A., Indrigo, J., Armitige, L. Y., Blackburn, M. R., Hunter, R. L., Actor, J. K.
(2008). A role for tumour necrosis factor-{alpha}, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response. Microbiology
154: 1813-1824
[Abstract]
[Full Text]
-
Guidry, T. V., Hunter, R. L. Jr, Actor, J. K.
(2007). Mycobacterial glycolipid trehalose 6,6'-dimycolate-induced hypersensitive granulomas: contribution of CD4+ lymphocytes. Microbiology
153: 3360-3369
[Abstract]
[Full Text]
-
Puissegur, M.-P., Lay, G., Gilleron, M., Botella, L., Nigou, J., Marrakchi, H., Mari, B., Duteyrat, J.-L., Guerardel, Y., Kremer, L., Barbry, P., Puzo, G., Altare, F.
(2007). Mycobacterial Lipomannan Induces Granuloma Macrophage Fusion via a TLR2-Dependent, ADAM9- and beta1 Integrin-Mediated Pathway. J. Immunol.
178: 3161-3169
[Abstract]
[Full Text]
-
Guidry, T. V., Hunter, R. L. Jr, Actor, J. K.
(2006). CD3+ cells transfer the hypersensitive granulomatous response to mycobacterial glycolipid trehalose 6,6'-dimycolate in mice. Microbiology
152: 3765-3775
[Abstract]
[Full Text]
-
Hunter, R. L., Olsen, M., Jagannath, C., Actor, J. K.
(2006). Trehalose 6,6'-Dimycolate and Lipid in the Pathogenesis of Caseating Granulomas of Tuberculosis in Mice. Am. J. Pathol.
168: 1249-1261
[Abstract]
[Full Text]
-
Hunter, R. L., Olsen, M. R., Jagannath, C., Actor, J. K.
(2006). Multiple Roles of Cord Factor in the Pathogenesis of Primary, Secondary, and Cavitary Tuberculosis, Including a Revised Description of the Pathology of Secondary Disease. Annals of Clinical & Laboratory Science
36: 371-386
[Abstract]
[Full Text]
-
Fujita, Y., Naka, T., Doi, T., Yano, I.
(2005). Direct molecular mass determination of trehalose monomycolate from 11 species of mycobacteria by MALDI-TOF mass spectrometry. Microbiology
151: 1443-1452
[Abstract]
[Full Text]
-
Geisel, R. E., Sakamoto, K., Russell, D. G., Rhoades, E. R.
(2005). In Vivo Activity of Released Cell Wall Lipids of Mycobacterium bovis Bacillus Calmette-Guerin Is Due Principally to Trehalose Mycolates. J. Immunol.
174: 5007-5015
[Abstract]
[Full Text]
-
Rao, V., Fujiwara, N., Porcelli, S. A., Glickman, M. S.
(2005). Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule. J. Exp. Med.
201: 535-543
[Abstract]
[Full Text]
-
Holten-Andersen, L., Doherty, T. M., Korsholm, K. S., Andersen, P.
(2004). Combination of the Cationic Surfactant Dimethyl Dioctadecyl Ammonium Bromide and Synthetic Mycobacterial Cord Factor as an Efficient Adjuvant for Tuberculosis Subunit Vaccines. Infect. Immun.
72: 1608-1617
[Abstract]
[Full Text]
-
Indrigo, J., Hunter, R. L. Jr, Actor, J. K.
(2002). Influence of trehalose 6,6'-dimycolate (TDM) during mycobacterial infection of bone marrow macrophages. Microbiology
148: 1991-1998
[Abstract]
[Full Text]
-
SUGAWARA, I., UDAGAWA, T., HUA, S.C., REZA-GHOLIZADEH, M., OTOMO, K., SAITO, Y., YAMADA, H.
(2002). Pulmonary granulomas of guinea pigs induced by inhalation exposure of heat-treated BCG Pasteur, purified trehalose dimycolate and methyl ketomycolate. J Med Microbiol
51: 131-137
[Abstract]
[Full Text]
-
Billiau, A., Matthys, P.
(2001). Modes of action of Freund's adjuvants in experimental models of autoimmune diseases. J. Leukoc. Biol.
70: 849-860
[Abstract]
[Full Text]